ArticleESMO gastrointestinal oncology2025

Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC study.

A Sartore-Bianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.